Retraction on “Dihydromyricetin attenuates inflammation through TLR4/NF-kappa B pathway”

Guardado en:

Detalles Bibliográficos
Autores principales:	Jing Nianshui, Li Xinnan
Formato:	article
Lenguaje:	EN
Publicado:	De Gruyter 2021
Materias:	Medicine R
Acceso en línea:	https://doaj.org/article/8eac74e283644da9a8eeee1826023936
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:8eac74e283644da9a8eeee1826023936
record_format	dspace
spelling	oai:doaj.org-article:8eac74e283644da9a8eeee18260239362021-12-05T14:10:55ZRetraction on “Dihydromyricetin attenuates inflammation through TLR4/NF-kappa B pathway”2391-546310.1515/med-2021-0331https://doaj.org/article/8eac74e283644da9a8eeee18260239362021-07-01T00:00:00Zhttps://doi.org/10.1515/med-2021-0331https://doaj.org/toc/2391-5463Jing NianshuiLi XinnanDe GruyterarticleMedicineRENOpen Medicine, Vol 16, Iss 1, Pp 1082-1082 (2021)
institution	DOAJ
collection	DOAJ
language	EN
topic	Medicine R
spellingShingle	Medicine R Jing Nianshui Li Xinnan Retraction on “Dihydromyricetin attenuates inflammation through TLR4/NF-kappa B pathway”
format	article
author	Jing Nianshui Li Xinnan
author_facet	Jing Nianshui Li Xinnan
author_sort	Jing Nianshui
title	Retraction on “Dihydromyricetin attenuates inflammation through TLR4/NF-kappa B pathway”
title_short	Retraction on “Dihydromyricetin attenuates inflammation through TLR4/NF-kappa B pathway”
title_full	Retraction on “Dihydromyricetin attenuates inflammation through TLR4/NF-kappa B pathway”
title_fullStr	Retraction on “Dihydromyricetin attenuates inflammation through TLR4/NF-kappa B pathway”
title_full_unstemmed	Retraction on “Dihydromyricetin attenuates inflammation through TLR4/NF-kappa B pathway”
title_sort	retraction on “dihydromyricetin attenuates inflammation through tlr4/nf-kappa b pathway”
publisher	De Gruyter
publishDate	2021
url	https://doaj.org/article/8eac74e283644da9a8eeee1826023936
work_keys_str_mv	AT jingnianshui retractionondihydromyricetinattenuatesinflammationthroughtlr4nfkappabpathway AT lixinnan retractionondihydromyricetinattenuatesinflammationthroughtlr4nfkappabpathway
_version_	1718371615473926144

Retraction on “Dihydromyricetin attenuates inflammation through TLR4/NF-kappa B pathway”

Ejemplares similares